Sustained release ranolazine formulations

  • US 6,503,911 B2
  • Filed: 10/19/2001
  • Issued: 01/07/2003
  • Est. Priority Date: 09/10/1998
  • Status: Expired due to Term
First Claim
Patent Images

1. A pharmaceutical dosage form comprising at least about 50 wt% ranolazine and the admixture of a pH-independent binder and a pH-dependent binder.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×